CPSA Shanghai 2016

Innovative Approaches to Reduce Attrition and Predict Clinical Outcomes

Organizing Committee

Program Chair
Kelly Dong GlaxoSmithKline China

Luke Bi Covance China
Joseph Bower Covance USA
Xiao-Yan Cai WuXi AppTec China
Ajai Chaudhary Merck USA
Swapan Chowdhury Takeda Pharmaceuticals USA
Paul Corcoran McKinley Scientific USA
Valeriu Damian-Iordache GlaxoSmithKline USA
Xiao Ding Genentech USA
Robert Dodge Bristol-Myers Squibb USA
Yi Du HuaHai Pharmaceutical Co., Ltd. China
Frank Fung MICE Partners China
Deepak Hedge GlaxoSmithKline China
Cornelis Hop Genentech USA
Wenying Jian Janssen Research & Development USA
Xiangyu Jiang WuXi AppTec China
Fan Jin Covance China
Kelli Jonakin SCIEX USA
David Jones MHRA UK
Jonathan Josephs Thermo Fisher Scientific USA
Chuan Li Shanghai Institute of Materia Medica China
Dongbei Li WuXi AppTec China
Fred Li Hua Medicine China
Eric Liang Novartis China
Jing Lin Sunovion China
George Liu Novartis China
Min Liu Merck USA
Qun Lu Celgene USA
Wenzhe Lu Roche China
Peiming Ma GlaxoSmithKline China
Shuguang Ma Genentech USA
Carla Marshall-Waggett New Objective USA
Marjoleen Nijsen AbbVie USA
Suma Ramagiri SCIEX USA
Jasminder Sahi Sanofi China
Yi-Min She Shanghai Center for Plant Stress Biology China
Jim Shen Bristol-Myers Squibb USA
Martin Steel McKinley Scientific USA
Philip Timmerman Janssen Research & Development Belgium
Gary Valaskovic New Objective USA
Frances Wang Janssen Research & Development
China
Sihe Wang Cleveland Clinic USA
Naidong Weng Janssen Research & Development USA
Mingdan Wu WuXi AppTec China
Keyang Xu Genentech China
Jiansong Yang MOSIM China
Nathan Yates University of Pittsburgh USA
Jeff Zhang Novartis China
Tianyi Zhang Frontage Laboratories China
Jenny Zheng Janssen Research & Development China
Sylvia Zhao Novartis China
Dafang Zhong Shanghai Institute of Materia Medica China